Literature DB >> 29254998

New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome.

Leah J Wilson1, Adam Linley2, Dean E Hammond1, Fiona E Hood1, Judy M Coulson1, David J MacEwan3, Sarah J Ross4, Joseph R Slupsky2, Paul D Smith4, Patrick A Eyers5, Ian A Prior6.   

Abstract

The human protein kinome comprises 535 proteins that, with the exception of approximately 50 pseudokinases, control intracellular signaling networks by catalyzing the phosphorylation of multiple protein substrates. While a major research focus of the last 30 years has been cancer-associated Tyr and Ser/Thr kinases, over 85% of the kinome has been identified to be dysregulated in at least one disease or developmental disorder. Despite this remarkable statistic, for the majority of protein kinases and pseudokinases, there are currently no inhibitors progressing toward the clinic, and in most cases, details of their physiologic and pathologic mechanisms remain at least partially obscure. By curating and annotating data from the literature and major public databases of phosphorylation sites, kinases, and disease associations, we generate an unbiased resource that highlights areas of unmet need within the kinome. We discuss strategies and challenges associated with characterizing catalytic and noncatalytic outputs in cells, and describe successes and new frontiers that will support more comprehensive cancer-targeting and therapeutic evaluation in the future. Cancer Res; 78(1); 15-29. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29254998     DOI: 10.1158/0008-5472.CAN-17-2291

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

Review 1.  Genetically encoded fluorescent biosensors illuminate kinase signaling in cancer.

Authors:  Wei Lin; Sohum Mehta; Jin Zhang
Journal:  J Biol Chem       Date:  2019-08-21       Impact factor: 5.157

2.  Tracing the origin and evolution of pseudokinases across the tree of life.

Authors:  Annie Kwon; Steven Scott; Rahil Taujale; Wayland Yeung; Krys J Kochut; Patrick A Eyers; Natarajan Kannan
Journal:  Sci Signal       Date:  2019-04-23       Impact factor: 8.192

3.  EMBER: Multi-label prediction of kinase-substrate phosphorylation events through deep learning.

Authors:  Kathryn E Kirchoff; Shawn M Gomez
Journal:  Bioinformatics       Date:  2022-02-14       Impact factor: 6.937

4.  A Novel Class of Common Docking Domain Inhibitors That Prevent ERK2 Activation and Substrate Phosphorylation.

Authors:  Rachel M Sammons; Nicole A Perry; Yangmei Li; Eun Jeong Cho; Andrea Piserchio; Diana P Zamora-Olivares; Ranajeet Ghose; Tamer S Kaoud; Ginamarie Debevec; Chandra Bartholomeusz; Vsevolod V Gurevich; Tina M Iverson; Marc Giulianotti; Richard A Houghten; Kevin N Dalby
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

5.  Kinome Profiling of Primary Endometrial Tumors Using Multiplexed Inhibitor Beads and Mass Spectrometry Identifies SRPK1 as Candidate Therapeutic Target.

Authors:  Alison M Kurimchak; Vikas Kumar; Carlos Herrera-Montávez; Katherine J Johnson; Nishi Srivastava; Karthik Davarajan; Suraj Peri; Kathy Q Cai; Gina M Mantia-Smaldone; James S Duncan
Journal:  Mol Cell Proteomics       Date:  2020-09-29       Impact factor: 5.911

6.  The ribosome: A hot spot for the identification of new types of protein methyltransferases.

Authors:  Steven G Clarke
Journal:  J Biol Chem       Date:  2018-05-09       Impact factor: 5.157

7.  Activation of RyR2 by class I kinase inhibitors.

Authors:  A D Chakraborty; L A Gonano; M L Munro; L J Smith; C Thekkedam; V Staudacher; A B Gamble; N Macquaide; A F Dulhunty; P P Jones
Journal:  Br J Pharmacol       Date:  2019-01-30       Impact factor: 8.739

Review 8.  Advances in quantitative high-throughput phosphoproteomics with sample multiplexing.

Authors:  Joao A Paulo; Devin K Schweppe
Journal:  Proteomics       Date:  2021-03-30       Impact factor: 3.984

9.  Development of cell-based high throughput luminescence assay for drug discovery in inhibiting OCT4/DNA-PKcs and OCT4-MK2 interactions.

Authors:  Ismail S Mohiuddin; Sung-Jen Wei; In-Hyoung Yang; Gloria M Martinez; Shengping Yang; Eun J Cho; Kevin N Dalby; Min H Kang
Journal:  Biotechnol Bioeng       Date:  2021-03-01       Impact factor: 4.530

Review 10.  Lemur Tyrosine Kinases and Prostate Cancer: A Literature Review.

Authors:  Elena Ferrari; Valeria Naponelli; Saverio Bettuzzi
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.